| Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections ND Friedman, KS Kaye, JE Stout, SA McGarry, SL Trivette, JP Briggs, ... Annals of internal medicine 137 (10), 791-797, 2002 | 1946 | 2002 |
| Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline CL Daley, JM Iaccarino, C Lange, E Cambau, RJ Wallace Jr, C Andrejak, ... Clinical Infectious Diseases 71 (4), e1-e36, 2020 | 1221 | 2020 |
| Cavitary pulmonary disease LB Gadkowski, JE Stout Clinical microbiology reviews 21 (2), 305-333, 2008 | 441 | 2008 |
| Update on pulmonary disease due to non-tuberculous mycobacteria JE Stout, WJ Koh, WW Yew International Journal of Infectious Diseases 45, 123-134, 2016 | 392 | 2016 |
| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 12 (1), 2349, 2021 | 349 | 2021 |
| Macrophage epithelial reprogramming underlies mycobacterial granuloma formation and promotes infection MR Cronan, RW Beerman, AF Rosenberg, JW Saelens, MG Johnson, ... Immunity 45 (4), 861-876, 2016 | 226 | 2016 |
| Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis AK Person, SM Chudgar, BL Norton, BC Tong, JE Stout Journal of medical microbiology 59 (7), 834-838, 2010 | 209 | 2010 |
| Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement J Van Ingen, T Aksamit, C Andrejak, EC Böttger, E Cambau, CL Daley, ... European Respiratory Journal 51 (3), 2018 | 196 | 2018 |
| Discriminating between latent and active tuberculosis with multiple biomarker responses M Frahm, ND Goswami, K Owzar, E Hecker, A Mosher, E Cadogan, ... Tuberculosis 91 (3), 250-256, 2011 | 175 | 2011 |
| Twenty-eight cases of Mycobacterium marinum infection: retrospective case series and literature review MG Johnson, JE Stout Infection 43, 655-662, 2015 | 161 | 2015 |
| In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated … BA Brown-Elliott, E Iakhiaeva, DE Griffith, GL Woods, JE Stout, CR Wolfe, ... Journal of clinical microbiology 51 (10), 3389-3394, 2013 | 157 | 2013 |
| Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium SE Dorman, S Goldberg, JE Stout, G Muzanyi, JL Johnson, M Weiner, ... The Journal of infectious diseases 206 (7), 1030-1040, 2012 | 140 | 2012 |
| Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection DP Holland, GD Sanders, CD Hamilton, JE Stout American journal of respiratory and critical care medicine 179 (11), 1055-1060, 2009 | 136 | 2009 |
| Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation AW Baker, SS Lewis, BD Alexander, LF Chen, RJ Wallace Jr, ... Clinical Infectious Diseases 64 (7), 902-911, 2017 | 135 | 2017 |
| Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial SE Dorman, RM Savic, S Goldberg, JE Stout, N Schluger, G Muzanyi, ... American journal of respiratory and critical care medicine 191 (3), 333-343, 2015 | 128 | 2015 |
| Advances in the management of pulmonary disease due to Mycobacterium abscessus complex WJ Koh, JE Stout, WW Yew The International journal of tuberculosis and lung disease 18 (10), 1141-1148, 2014 | 117 | 2014 |
| Risk factors for ineffective therapy in patients with bloodstream infection JR McDonald, ND Friedman, JE Stout, DJ Sexton, KS Kaye Archives of internal medicine 165 (3), 308-313, 2005 | 110 | 2005 |
| Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study DJ Anderson, DR Murdoch, DJ Sexton, LB Reller, JE Stout, CH Cabell, ... Infection 32, 72-77, 2004 | 100 | 2004 |
| Text messaging for enhancement of testing and treatment for tuberculosis, human immunodeficiency virus, and syphilis: a survey of attitudes toward cellular phones and healthcare AK Person, MLM Blain, H Jiang, PW Rasmussen, JE Stout Telemedicine and e-Health 17 (3), 189-195, 2011 | 96 | 2011 |
| Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis JE Stout, JJ Engemann, AC Cheng, ER Fortenberry, CD Hamilton American journal of respiratory and critical care medicine 167 (6), 824-827, 2003 | 95 | 2003 |
Carol D HamiltonProfessor, Duke University在 fhi360.org 的电子邮件经过验证
